Immunocore prepays $52M Pharmakon loan, terminating agreement 4 years early

Immunocore Holdings plc

Immunocore prepaid $52M ($50M principal, $0.5M interest, $1.5M prepayment premium) on Nov 8, 2024.
Full repayment terminates all obligations under Pharmakon Loan Agreement originally due Nov 8, 2028.
Loan was from BioPharma Credit entities; collateral agent BioPharma Credit PLC.
Subsidiary Immunocore Limited was borrower; parent Immunocore Holdings as credit party.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.